CompletedNot Applicable

Validation of the Concept of the Autoantibodies Directed Against the Neuropeptides Involved in Food Intake Regulation on the Incidental Cases of Eating Disorders

France211 participantsStarted 2018-05-24

Plain-language summary

This study should lead to the validation of the concept of the autoAc directed against the neuropeptides involved in food intake regulation.

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. 18 Years and older
✓. first clinical visit in nutrition department of CHU de Rouen for eating disorders
✓. anorexia nervosa, hyperphagia or bulimia according to the classification DSM-V
✓. social security Affiliation
✓. Patient who signed the MEC approved informed consent
✓. 18 Years to 60 Years
✓. body mass index ≥ 18,5 kg/m2 and ≤ 24,9 kg/m2
✓. negative SCOFF test

Exclusion criteria

✕. No anorexia nervosa, hyperphagia or bulimia according to the classification DSM-V
✕. Adults under legal protection or under safeguard of justice or administrative decision
✕. Pregnancy
✕. Active or history of eating disorder
✕. Adults under legal protection or under safeguard of justice or administrative decision
✕. Pregnancy

What they're measuring

Evaluation of the rates of the autoantibodies directed against the neuropeptides (ghrelin and alpha-MSH) involved in food intake regulation among patients with eating disorders

Timeframe: 1 week

Trial details

NCT IDNCT03510533

SponsorUniversity Hospital, Rouen

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-08-13

View on ClinicalTrials.gov More Eating Disorder trials